2022 Q1 Form 10-Q Financial Statement

#000165495422006389 Filed on May 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q1
Revenue $12.41M $15.07M $11.03M
YoY Change 12.54% 64.68% 16.78%
Cost Of Revenue $10.84M $16.93M $12.50M
YoY Change -13.34% 89.51% 11.92%
Gross Profit $1.574M -$1.859M -$1.477M
YoY Change -206.57% -952.75% -14.57%
Gross Profit Margin 12.68% -12.34% -13.4%
Selling, General & Admin $3.925M $5.403M $3.901M
YoY Change 0.62% 15.65% -22.24%
% of Gross Profit 249.36%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.511M $1.342M $908.0K
YoY Change 66.41% -37.58% -5.71%
% of Gross Profit 96.0%
Operating Expenses $3.925M $5.965M $4.225M
YoY Change -7.1% 21.71% -21.47%
Operating Profit -$2.459M -$7.824M -$5.702M
YoY Change -56.87% 67.07% -19.79%
Interest Expense $1.310M -$1.568M $831.0K
YoY Change 57.64% -5.37% -208.63%
% of Operating Profit
Other Income/Expense, Net -$1.523M -$243.0K -$954.0K
YoY Change 59.64% -111.46% -3916.0%
Pretax Income -$3.982M -$9.992M -$6.656M
YoY Change -40.17% 146.53% -15.2%
Income Tax $75.00K $0.00 $63.00K
% Of Pretax Income
Net Earnings -$4.057M -$9.992M -$6.719M
YoY Change -39.62% 143.23% -14.67%
Net Earnings / Revenue -32.69% -66.3% -60.94%
Basic Earnings Per Share -$0.04 -$0.13
Diluted Earnings Per Share -$0.04 -$151.1K -$0.13
COMMON SHARES
Basic Shares Outstanding 100.1M shares 99.41M shares 53.59M shares
Diluted Shares Outstanding 100.1M shares 53.59M shares

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.886M $7.887M $13.57M
YoY Change -56.63% -69.37% 2212.1%
Cash & Equivalents $5.886M $7.887M $13.57M
Short-Term Investments
Other Short-Term Assets $2.702M $1.976M $2.533M
YoY Change 6.67% -69.08% -21.19%
Inventory $15.81M $13.34M $13.89M
Prepaid Expenses
Receivables $5.644M $8.222M $7.118M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $30.04M $31.43M $37.11M
YoY Change -19.06% -32.56% 60.81%
LONG-TERM ASSETS
Property, Plant & Equipment $63.83M $64.78M $49.46M
YoY Change 29.07% 31.55% 14.34%
Goodwill $357.0K
YoY Change
Intangibles $40.67M $40.76K
YoY Change -94.46%
Long-Term Investments
YoY Change
Other Assets $346.0K $416.0K $591.0K
YoY Change -41.46% -12.61% -74.01%
Total Long-Term Assets $104.9M $106.0M $87.34M
YoY Change 20.05% 108.52% 83.65%
TOTAL ASSETS
Total Short-Term Assets $30.04M $31.43M $37.11M
Total Long-Term Assets $104.9M $106.0M $87.34M
Total Assets $134.9M $137.4M $124.5M
YoY Change 8.39% 41.02% 76.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.317M $3.102M $3.352M
YoY Change -30.88% 45.16% -6.08%
Accrued Expenses $744.0K $650.0K $900.0K
YoY Change -17.33% -46.37% 37.4%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $258.00 $221.00 $3.296M
YoY Change -99.99% -81.78% 32.42%
Total Short-Term Liabilities $12.05M $10.12M $14.75M
YoY Change -18.32% -35.62% 12.14%
LONG-TERM LIABILITIES
Long-Term Debt $23.03K $22.90K $49.80M
YoY Change -99.95% 63.5% 43.55%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $23.03K $22.90K $49.80M
YoY Change -99.95% 63.5% 39.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.05M $10.12M $14.75M
Total Long-Term Liabilities $23.03K $22.90K $49.80M
Total Liabilities $68.48M $67.07M $64.55M
YoY Change 6.09% 1.23% 32.3%
SHAREHOLDERS EQUITY
Retained Earnings -$119.1M
YoY Change 26.15%
Common Stock $189.4M
YoY Change 50.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $66.41M $70.31M $59.90M
YoY Change
Total Liabilities & Shareholders Equity $134.9M $137.4M $124.5M
YoY Change 8.39% 41.02% 76.19%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q1
OPERATING ACTIVITIES
Net Income -$4.057M -$9.992M -$6.719M
YoY Change -39.62% 143.23% -14.67%
Depreciation, Depletion And Amortization $1.511M $1.342M $908.0K
YoY Change 66.41% -37.58% -5.71%
Cash From Operating Activities -$874.0K -$7.585M -$9.271M
YoY Change -90.57% -950.34% 294.34%
INVESTING ACTIVITIES
Capital Expenditures $483.0K -$1.536M $373.0K
YoY Change 29.49% -43.94% -130.4%
Acquisitions $0.00 $4.569M
YoY Change -100.0%
Other Investing Activities $0.00 $486.0K -$2.589M
YoY Change -100.0% -132.4% 4442.11%
Cash From Investing Activities -$483.0K -$1.050M -$2.962M
YoY Change -83.69% -75.24% 130.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$644.0K -473.0K $54.00K
YoY Change -1292.59% -102.01% -98.12%
NET CHANGE
Cash From Operating Activities -$874.0K -7.585M -$9.271M
Cash From Investing Activities -$483.0K -1.050M -$2.962M
Cash From Financing Activities -$644.0K -473.0K $54.00K
Net Change In Cash -$2.001M -9.108M -$12.18M
YoY Change -83.57% -145.04% 1510.98%
FREE CASH FLOW
Cash From Operating Activities -$874.0K -$7.585M -$9.271M
Capital Expenditures $483.0K -$1.536M $373.0K
Free Cash Flow -$1.357M -$6.049M -$9.644M
YoY Change -85.93% -266.55% 758.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
100288094 shares
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
827000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1139000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
134892000 USD
CY2021Q1 lowlf Issuance Of Shares Associated With Acquisitions Shares Amount
IssuanceOfSharesAssociatedWithAcquisitionsSharesAmount
34237 USD
CY2021Q1 lowlf Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
665 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
287 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
59903000 USD
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-4057000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-6719000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1511000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
908000 USD
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
226000 USD
CY2021Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
204000 USD
CY2021Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
106000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
1310000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
831000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1523000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
161000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
287000 USD
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
243000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2164000 USD
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1761000 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
224000 USD
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1441000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-954000 USD
CY2022Q1 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
0 USD
CY2021Q1 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
152000 USD
CY2022Q1 lowlf Unrealized Gain On Change In Fair Value Of Investments
UnrealizedGainOnChangeInFairValueOfInvestments
70000 USD
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
108000 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
324000 USD
CY2021Q1 lowlf Unrealized Gain On Change In Fair Value Of Investments
UnrealizedGainOnChangeInFairValueOfInvestments
-106000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2335000 USD
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
4033000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2471000 USD
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2464000 USD
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53592000 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
70307000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
161 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
66411000 USD
CY2021Q1 us-gaap Revenues
Revenues
11026000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
31156000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-143000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-229000 USD
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-70000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-6719000 USD
CY2021Q1 lowlf Shares Issued In Connection With Conversion Of Convertible Debentures Amount
SharesIssuedInConnectionWithConversionOfConvertibleDebenturesAmount
277 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
4225000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2459000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5702000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6656000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
75000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
63000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4057000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-6719000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100118000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53592000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100118000 shares
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-653000 USD
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-726000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1827000 USD
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
3050000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2146000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-874000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9271000 USD
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
730000 USD
CY2022Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2021Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1980000 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
483000 USD
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
60720000 USD
CY2022Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
82 USD
CY2021Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
9 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1058000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-9000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
373000 USD
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
4569000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-483000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2962000 USD
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
586000 USD
CY2021Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
580000 USD
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
58000 USD
CY2021Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
31000 USD
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
665000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-644000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
54000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2001000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-12179000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7887000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
25751000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5886000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13572000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
1018000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
846000 USD
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
268000 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
91000 USD
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
79000 USD
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
CY2022Q1 us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
0 USD
CY2021Q1 us-gaap Noncash Or Part Noncash Acquisition Debt Assumed1
NoncashOrPartNoncashAcquisitionDebtAssumed1
34237000 USD
CY2022Q1 lowlf Liabilities Assumed And Receivable Forgiveness In Exchange For Net Assets Acquired8b
LiabilitiesAssumedAndReceivableForgivenessInExchangeForNetAssetsAcquired8b
0 USD
CY2021Q1 lowlf Liabilities Assumed And Receivable Forgiveness In Exchange For Net Assets Acquired8b
LiabilitiesAssumedAndReceivableForgivenessInExchangeForNetAssetsAcquired8b
2910000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
0 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
665000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
13343000 USD
CY2022Q1 lowlf Future Amortization Expense
FutureAmortizationExpense
325 USD
CY2022Q1 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.082 pure
CY2021 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.078 pure
CY2022Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
4019000 USD
CY2022Q1 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
618000 USD
CY2022Q1 us-gaap Business Combination Consideration Transferred Liabilities Incurred
BusinessCombinationConsiderationTransferredLiabilitiesIncurred
12115000 USD
CY2022Q1 us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
43968000 USD
CY2022Q1 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
60720000 USD
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
3300000 USD
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
1312000 USD
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Land
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand
8261000 USD
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Buildings
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings
6268000 USD
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment
1221000 USD
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
739000 USD
CY2022Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
37299000 USD
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates in these financial statements include allowance for doubtful accounts and credit losses, carrying value of inventory, revenue recognition, accounting for stock-based compensation expense, and income taxes. Actual results could differ from those estimates.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The global COVID-19 pandemic has impacted the operations and purchasing decisions of companies worldwide. It also has created and may continue to create significant uncertainty in the global economy. The Company has undertaken measures to protect its employees, partners, customers, and vendors. In addition, the Company’s personnel are subject to various travel restrictions, which limit the ability of the Company to provide services to customers and affiliates. This impacts the Company’s normal operations. To date, the Company has been able to provide uninterrupted access to its products and services, including certain employees that are working remotely, and its pre-existing infrastructure that supports secure access to the Company’s internal systems. If, however, the COVID-19 pandemic has a substantial impact on the productivity of the Company’s employees or its partners’ or customers’ decision to use the Company’s products and services, the results of the Company’s operations and overall financial performance may be adversely impacted. The duration and extent of the impact from the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time. As of the date of issuance of the financial statements, the Company is not aware of any specific event or circumstance that would require updates to the Company’s estimates and judgments or revisions to the carrying value of its assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and are recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the financial statements.</p>
CY2022Q1 lowlf Interest Rate
InterestRate
0.125 pure
CY2022Q1 us-gaap Deposits Assets Current
DepositsAssetsCurrent
548000 USD
CY2021Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
548000 USD
CY2022Q1 us-gaap Prepaid Insurance
PrepaidInsurance
608000 USD
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
624000 USD
CY2022Q1 us-gaap Supplies
Supplies
1395000 USD
CY2021Q4 us-gaap Supplies
Supplies
575000 USD
CY2022Q1 us-gaap Interest Receivable
InterestReceivable
98 USD
CY2021Q4 us-gaap Interest Receivable
InterestReceivable
147 USD
CY2022Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
53000 USD
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
82000 USD
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2702000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1976000 USD
CY2022Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
10379000 USD
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
8558000 USD
CY2022Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
110 USD
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
292000 USD
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5318000 USD
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4493000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
15807000 USD
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1669 USD
CY2021 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1875 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
40756000 USD
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
40674000 USD
CY2022Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
4754000 USD
CY2021Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
2830000 USD
CY2022Q1 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
77000 USD
CY2021Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
78000 USD
CY2022Q1 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1078000 USD
CY2021Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
651000 USD
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
315000 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
147000 USD
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6224000 USD
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3706000 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
76053000 USD
CY2022Q1 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
483000 USD
CY2022Q1 lowlf Property Plant And Equipment Business Acquisition Additions
PropertyPlantAndEquipmentBusinessAcquisitionAdditions
0 USD
CY2022Q1 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0 USD
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
76536000 USD
CY2021Q4 lowlf Accumulated Depreciation Beginning
AccumulatedDepreciationBeginning
11274000 USD
CY2022Q1 us-gaap Depreciation
Depreciation
1429000 USD
CY2022Q1 lowlf Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Disposals
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentDisposals
0 USD
CY2022Q1 lowlf Accumulated Depreciation Ending
AccumulatedDepreciationEnding
-12703000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
63833000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
64779000 USD
CY2022Q1 us-gaap Depreciation
Depreciation
1429000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
899000 USD
CY2022Q1 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
0 USD
CY2022Q1 lowlf Finite Lived Intangible Assets Agreement Termination
FiniteLivedIntangibleAssetsAgreementTermination
0 USD
CY2022Q1 lowlf Definite Lived Intangible Assets
DefiniteLivedIntangibleAssets
40965000 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
209 USD
CY2022Q1 lowlf Agreement Termination Amortization
AgreementTerminationAmortization
0 USD
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
-82000 USD
CY2022Q1 lowlf Other Accumulated Amortization
OtherAccumulatedAmortization
0 USD
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
291 USD
CY2021Q4 lowlf Total Indebtness
TotalIndebtness
23118 USD
CY2022Q1 lowlf Warrants Beginning Balance
WarrantsBeginningBalance
93897000 shares
CY2022Q1 lowlf Warrants Ending Balance
WarrantsEndingBalance
93897000 shares
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
258 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
221 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
23028 USD
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
22897 USD
CY2022Q1 lowlf Total Indebtness
TotalIndebtness
23286 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
193000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
15783000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
311000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
352000 USD
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
8317000 USD
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
24956000 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
36496000 USD
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
586000 USD
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
35910 USD
CY2022Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2503000 USD
CY2021Q1 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2444000 USD
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
33407000 USD
CY2021Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
34052000 USD
CY2022Q1 us-gaap Capital Lease Obligations
CapitalLeaseObligations
35910000 USD
CY2021Q1 us-gaap Capital Lease Obligations
CapitalLeaseObligations
36496000 USD
CY2022Q1 us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
817000 USD
CY2021 us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
742000 USD
CY2022Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
573000 USD
CY2021 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
563000 USD
CY2022Q1 us-gaap Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
1390000 USD
CY2021 us-gaap Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
1305000 USD
CY2022Q1 lowlf Weighted Average Remaining Lease Term
WeightedAverageRemainingLeaseTerm
P14Y8M12D
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06 pure
CY2021 lowlf Weighted Average Remaining Lease Term
WeightedAverageRemainingLeaseTerm
P17Y2M12D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06 pure
CY2022Q1 lowlf Lessee Operating Lease Liability Payments Due Year One
LesseeOperatingLeaseLiabilityPaymentsDueYearOne
3948 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4890 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4280000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
3451 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
43038000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
59607000 USD
CY2022Q1 us-gaap Receivable With Imputed Interest Discount
ReceivableWithImputedInterestDiscount
23697 USD
CY2022Q1 lowlf Total
Total
35910 USD
CY2022Q1 lowlf Proceeds From Issuance Of Stock Options
ProceedsFromIssuanceOfStockOptions
13200000 shares
CY2022Q1 lowlf Stock Option For Future Grant
StockOptionForFutureGrant
2300000 shares
CY2022Q1 lowlf Vesting Period Descriptions
VestingPeriodDescriptions
The awards granted generally vest in 25% increments over a four-year period and option awards expire 6 years from grant date
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
1.11
CY2022Q1 lowlf Rsus Outstanding Ending Balance
RsusOutstandingEndingBalance
487000 shares
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
161000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6598000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.99
CY2022Q1 lowlf Weighted Average Remaining Contactual Life Outstanding Beginning Balance
WeightedAverageRemainingContactualLifeOutstandingBeginningBalance
P4Y3M18D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3240000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.31
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2022Q1 lowlf Stock Options Cancelled
StockOptionsCancelled
-879000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.99
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8959 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.74
CY2022Q1 lowlf Weighted Average Remaining Contactual Life Outstanding Ending Balance
WeightedAverageRemainingContactualLifeOutstandingEndingBalance
P4Y6M
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3688000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.87
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y6M
CY2022Q1 lowlf Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableIntrinsicValue
30000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
8959000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.74
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y6M
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
261000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.31
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.58
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
926000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P2Y3M18D
CY2022Q1 lowlf Rsus Outstanding Beginning Balance
RsusOutstandingBeginningBalance
642000 shares
CY2022Q1 lowlf Weighted Average Fair Value Outstanding Beginning Balance
WeightedAverageFairValueOutstandingBeginningBalance
1.18
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
125000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
1.49
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
30000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100118000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53592000 shares
CY2022Q1 lowlf Weighted Average Fair Value Outstanding Ending Balance
WeightedAverageFairValueOutstandingEndingBalance
1.11
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
75000 USD
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0188 pure
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
63000 USD
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0095 pure
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-4057000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-6719000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100118000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53592000 shares
CY2022Q1 us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
100118000 shares
CY2021Q1 us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
53592000 shares
CY2022Q1 lowlf Basic Shares
BasicShares
100118000 shares
CY2021Q1 lowlf Basic Shares
BasicShares
53592000 shares
CY2022Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
0 USD
CY2021Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
0 USD
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2022Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
CY2021Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
CY2022Q1 lowlf Restricted Stock Units
RestrictedStockUnits
0 USD
CY2021Q1 lowlf Restricted Stock Units
RestrictedStockUnits
0 USD

Files In Submission

Name View Source Status
0001654954-22-006389-index-headers.html Edgar Link pending
0001654954-22-006389-index.html Edgar Link pending
0001654954-22-006389.txt Edgar Link pending
0001654954-22-006389-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lowlf-20220331.xsd Edgar Link pending
lowlf-20220331_cal.xml Edgar Link unprocessable
lowlf-20220331_def.xml Edgar Link unprocessable
lowlf-20220331_lab.xml Edgar Link unprocessable
lowlf-20220331_pre.xml Edgar Link unprocessable
lowlf_10q.htm Edgar Link pending
lowlf_10q_htm.xml Edgar Link completed
lowlf_ex311.htm Edgar Link pending
lowlf_ex312.htm Edgar Link pending
lowlf_ex321.htm Edgar Link pending
lowlf_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending